Neurodegeneration: Etiologies and New Therapies 2016

Eng King Tan 1 and Amit K. Srivastava 2 and W. David Arnold 3 and Mahendra P. Singh 4 and Yiying Zhang 5 1, Department of Neurology, Singapore General Hospital, National Neuroscience Institute and Duke NUS Graduate Medical School, 169857, Singapore 2, Department of Pediatric Surgery, University of Texas Health Sciences Center at Houston, Houston, TX 77030, USA 3, Department of Neurology, Division of Neuromuscular Disorders and Department of PM&R and Department of Neuroscience, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA 4, Toxicogenomics and Predictive Toxicology Division, CSIR-Indian Institute of Toxicology Research, Lucknow, Uttar Pradesh 226 001, India 5, Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA Received 3 October 2016; Accepted 5 October 2016; 3 November 2016 This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.